Challenges in ESI-MS-based Untargeted Metabolomics.

Annotation Capillary electrophoresis Liquid chromatography Mass spectrometry Metabolomics Supercritical fluid chromatography Toxicological and doping analysis

Journal

Chimia
ISSN: 0009-4293
Titre abrégé: Chimia (Aarau)
Pays: Switzerland
ID NLM: 0373152

Informations de publication

Date de publication:
23 Feb 2022
Historique:
received: 26 10 2021
accepted: 14 12 2021
medline: 23 2 2022
pubmed: 23 2 2022
entrez: 9 12 2023
Statut: epublish

Résumé

Untargeted metabolomics is now widely recognized as a useful tool for exploring metabolic changes taking place in biological systems under different conditions. In this article, we aim to provide a short overview of the liquid-phase separation methods hyphenated to MS to perform untargeted metabolomics of biological samples. Each approach is complemented by up-to-date literature to guide readers, as well as practical information for avoiding or fixing some of the most frequently encountered pitfalls. This article covers mainly data acquisition, but a short discussion is provided regarding signal processing and data treatment, as well as data analysis and its biological interpretation in the context of metabolomic studies.

Identifiants

pubmed: 38069754
doi: 10.2533/chimia.2022.90
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

90-100

Informations de copyright

Copyright 2022 Serge Rudaz, Elena Tobolkina, Víctor González-Ruiz, Isabel Meister, Miguel De Figueiredo, Davy Guillarme, Julien Boccard. License: This work is licensed under a Creative Commons Attribution 4.0 International License.

Auteurs

Elena Tobolkina (E)

School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. Elena.Tobolkina@unige.ch.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.

Víctor González-Ruiz (V)

School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. Victor.Gonzalez@unige.ch.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland.

Isabel Meister (I)

School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. Isabel.Meister@unige.ch.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.

Miguel De Figueiredo (M)

School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. Miguel.DeFigueiredo@unige.ch.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.

Davy Guillarme (D)

School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. davy.guillarme@unige.ch.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.

Julien Boccard (J)

School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. julien.boccard@unige.ch.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland.

Serge Rudaz (S)

School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. serge.rudaz@unige.ch.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland.

Classifications MeSH